Trial record 1 of 1 for:
JZP898 | Solid Tumor
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT06108050 |
|
Recruitment Status :
Recruiting
First Posted : October 30, 2023
Last Update Posted : April 19, 2024
|
Sponsor:
Jazz Pharmaceuticals
Collaborator:
Merck Sharp & Dohme LLC
Information provided by (Responsible Party):
Jazz Pharmaceuticals
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | November 30, 2027 |
| Estimated Study Completion Date : | May 31, 2028 |